Amendments to related matters that OBI forfeits part of subscription rights of Obigen’s cash capital increase and distributes the rights to its shareholders

1.Date of occurrence of the event:2022/11/28 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: Not applicable 5.Cause of occurrence: The Company announced that OBI forfeited part of the preemptive rights of Obigen’s 2022 cash capital increase and distributed the rights to shareholders of OBI […]

This article is password protected.

To view the content, please enter your password in the field below